Zantac is a brand name for the generic drug ranitidine, which was found to contain a chemical that is a probable human carcinogen. Because of the recent discovery of this potentially cancerous chemical, the FDA has urged drugmakers to voluntarily recall the product.
As of early 2020, several drug manufacturers have recalled products containing ranitidine. Several pharmaceutical retailers, including CVS and Walgreens, have pulled Zantac and other ranitidine medications from their shelves, suspending sales of such drugs indefinitely.
Whether Zantac can cause lung cancer is unknown at this time. What is known is that multiple sources have found a chemical called N-nitrosodimethylamine (NDMA) in various ranitidine products. An overexposure of NDMA may reduce lung function or lead to cancer.
Does NDMA In Zantac Cause Lung Cancer?
NDMA has also been associated with valsartan, a medication used to treat high blood pressure. A recent valsartan study conducted in Denmark was inconclusive about NDMA increasing the risk of cancer in humans. However, the authors noted that there is an association between NDMA and cancer, and regulators were wise to recall the product.
This same logic can be applied to Zantac and lung cancer. Although it may not be clear if Zantac actually causes lung cancer, there is a known risk. People taking Zantac should consult with their doctor about switching medications, and pharmaceutical companies should voluntarily recall medications that contain NDMA.
Understanding The Cancerous Chemical In Zantac (Ranitidine)
To understand if Zantac contributes to the development of lung cancer, it helps to further your understanding of NDMA. NDMA is an organic chemical that forms in natural or industrial processes, but is not produced in any form (unless for research purposes). It is classified as a B2 carcinogen, which means it could cause cancer.
Human beings are most likely exposed to NDMA by ingesting it orally.
You can be exposed to NMDA through a variety of sources, including:
- smoking or chewing tobacco
- eating cured meats like bacon
- drinking beer
- eating fish or cheese
- in toiletries or cosmetic products
- ingesting Zantac, ranitidine, valsartan, and other medications
The Link Between NDMA And Cancer
NDMA is linked to cancer because of animal studies. When mice, hamsters, rats, and other animals drank water, ate food, or breathed air contaminated with low levels of NMDA for several weeks, they developed lung cancer. Because of this, it’s reasonable to assume that repeated exposure to NMDA in human beings can lead to lung cancer.
Common Causes Of Lung Cancer
There are two main types of lung cancer. Small cell lung cancer and non-small cell lung cancer. Each type is named for the appearance of the cancerous cells under a microscope. These cells grow and spread in different ways. Smoking is the most common cause of both types of lung cancer, but it’s possible for nonsmokers to develop lung cancer as well.
Other known causes of lung cancer include HIV infection, a family history of lung cancer, and exposure to:
- secondhand smoke
- air pollution
Lung Cancer Survival Rate
Lung cancer is the leading cause of cancer death for both men and women in the United States. In 2016, lung cancer was reported in 13 percent of all new cancer cases. This means that out of 100 people diagnosed with cancer, 13 people developed lung cancer.
The five-year survival rate for lung cancer is roughly 18 percent. This means that out of 100 people diagnosed with lung cancer, 18 people hadn’t died five years after a diagnosis.
If you have any signs of lung cancer, please consult with your physician immediately. If you have already developed lung cancer, and have a history of taking Zantac or other ranitidine products, you have options for legal recourse.
Our Featured Case Results
What You Should Do If You Have Lung Cancer And Have Taken Zantac
Although it can be difficult to pinpoint a single cause for developing lung cancer, taking Zantac may increase the risk. If you or someone you love has lung cancer and has ever taken Zantac, you can pursue legal action.
Regardless of how long you’ve had lung cancer or taken Zantac, you can take legal action against the manufacturers of Zantac for failing to warn the public about the potential risks for cancer. Although it can’t be proven Zantac caused your lung cancer, you may still have a legal case for collecting damages.
We Are Nationally Awarded Lawyers
Contact Florin|Roebig For Help Filing A Zantac Lawsuit
Dealing with lung cancer is hard enough, but learning that a supposedly safe medication may have contributed to your development of cancer can be confusing and frustrating. At Florin|Roebig, we offer free case evaluations to help you decide if you should file a lawsuit.
Our skilled dangerous drug attorneys will assess your case. The simple fact is that if you have lung cancer and took Zantac daily or frequently, then you likely have a case against pharmaceutical companies who can be held liable for damages.
Contact Florin|Roebig to begin your free case evaluation today.